- Drug Pipelines
- August 2024
- 150 Pages
Global
From €3567EUR$3,750USD£3,003GBP
- Report
- September 2024
- 179 Pages
Global
From €2378EUR$2,500USD£2,002GBP
- Report
- October 2024
- 250 Pages
Global
From €3800EUR$3,995USD£3,199GBP
- Report
- January 2024
- 348 Pages
Global
From €5348EUR$5,819USD£4,350GBP
- Report
- November 2023
Global
From €4709EUR$4,950USD£3,964GBP
- Report
- October 2024
- 186 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 187 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 197 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 184 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 186 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 189 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 182 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 180 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 183 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 185 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 192 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 186 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 184 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 192 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
- Report
- October 2024
- 184 Pages
Global
From €3372EUR$3,545USD£2,839GBP
€3747EUR$3,939USD£3,154GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more